ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00782613
Recruitment Status : Terminated (Study has been termination early due to financial contraints.)
First Posted : October 31, 2008
Last Update Posted : January 30, 2009
Sponsor:
Information provided by:
Synvista Therapeutics, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : March 2009
  Estimated Study Completion Date : March 2009